NEWS
Omicron variant isolated by HKU microbiology research team
30 Nov 2021
This is the first known research team in Asia that has succeeded in isolating the Omicron variant. The isolated variant will enable the development and production of vaccines against Omicron, which has been designated as a "variant of concern" by the World Health Organization. [...]
Prof KY Yuen Receive 2021 Future Science Prize
13 Sep 2021
Two distinguished scholars from the Li Ka Shing Faculty of Medicine, The University of Hong Kong (HKUMed), Professor Yuen Kwok-Yung and Professor Joseph Sriyal Malik Peiris, have been awarded the 2021 Future Science Prize in life sciences for their contributions in pathological discoveries in severe acute respiratory syndrome (SARS) in 2003 and its zoonotic origin, with impact on combating COVID-19. [...]
Prof ZW Chen identifies BiIA-SG as a promising universal drug for HIV-1 prevention and functional cure
27 Aug 2021
A multi-institutional research team led by scientists at the AIDS Institute and Department of Microbiology, LKS Faculty of Medicine of The University of Hong Kong (HKUMed) has identified BilA-SG, a tandem bi-specific broadly neutralising antibody, as a promising universal drug for human immunodeficiency virus-1 (HIV-1) prevention and functional cure. [...]
Dr Hin Chu awarded China's Excellent Young Scientists Fund 2021
22 Aug 2021
Dr Hin Chu has been awarded the prestigious fund under the National Natural Science Foundation of China, an organisation managed by the Ministry of Science and Technology (MOST).
The Excellent Young Scientists Fund is granted annually to support young male scientists under the age of 38 and young female scientists under the age of 40 who have attained outstanding achievements in research, to further expand in areas of their own choice. [...]
Dr Yuan Shuofeng and Dr Jenny Lam develop inhaled dry powder formulation of broad-spectrum antiviral against COVID-19 and influenza
26 Jul 2021
The collaborative research team formed by the Department of Pharmacology and Pharmacy and Department of Microbiology, LKS Faculty of Medicine, The University of Hong Kong (HKUMed) has developed an inhalable dry powder formulation of tamibarotene, a repurposed drug that exhibits broad-spectrum antiviral activity against SARS-CoV-2, MERS-CoV and influenza A H1N1 virus following pulmonary delivery. The work has been published online in Advanced Therapeutics in June 2021. [...]
HKU State Key Laboratory of Emerging Infectious Diseases discovers Novel Coronavirus Mutant at early phase of pandemic with characteristics of attenuated vaccine
14 May 2021
The SARS-CoV-2 coronavirus was first discovered in Wuhan, China at the end of 2019. Evidence from genome analysis studies indicated that this is a cross-species transmission of the novel coronavirus. It is believed that SARS-CoV-2 coronavirus will continue to adapt to human through infection and transmission. [...]
A globally accessible therapy is found to protect against lethal inflammation from COVID-19 in animal models
1 Apr 2021
Mount Sinai researchers, in a collaboration with scientists at the LKS Faculty of Medicine, The University of Hong Kong (HKUMed), have found that a widely available and inexpensive drug targeting inflammatory genes has reduced morbidity and mortality in mice infected with SARS-CoV-2, [...]
HKU's COVID-19 intranasal vaccine updates (Q&A)
26 Mar 2021
Sources of information:
-
Professor Yuen Kwok-yung, Chair professor of Infectious Diseases, Department of Microbiology, Li Ka Shing Faculty of Medicine, the University of Hong Kong
-
Professor Chen Honglin, Department of Microbiology, Li Ka Shing Faculty of Medicine, the University of Hong Kong
-
HKU Clinical Trials Centre [...]
.png){kind=logo}
CONTACT US
E-mail: admin@cvvt.hk
Tel: 3910 3688
Fax: 3753 2284
Address:
1. Laboratory: Unit 208-213, 2/F, Building 15W, Hong Kong Science Park, Pak Shek Kok, N.T.
2. Office: Unit 313-316, 3/F,
Building 17W, Hong Kong Science Park, Pak Shek Kok, N.T.